GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

1. Uterine Cancer Global Clinical Trials Review, H1, 2016
Summary:
GlobalData's clinical trial report, “Uterine Cancer Global Clinical Trials Review, H1, 2016" provides an
overview of Uterine Cancer clinical trials scenario. This report provides top line data relating to the
clinical trials on Uterine Cancer. Report includes an overview of trial numbers and their average
enrollment in top countries conducted across the globe. The report offers coverage of disease clinical
trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical
Trial Reports are generated using GlobalData’ s proprietary database - Pharma eTrack Clinical trials
database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals,
news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies
to gain competitive advantage.
View complete pharmaceuticals report With TOC @:
https://marketreportscenter.com/reports/310629/uterine-cancer-global-clinical-trials-
review-h1-2016
*Note: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status,
Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status)
pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason
for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.

2. Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business
opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed
and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.
Click here for sample of this Report @: https://marketreportscenter.com/request-sample/310629
Table of Content
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Uterine Cancer to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Uterine Cancer to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25

3. Prominent Sponsors 26
Top Companies Participating in Uterine Cancer Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Uterine Cancer 29
Apr 17, 2016: Precision Biologics, a NantWorks Company, to Present Combination Immunotherapy of a
Novel Neo-Epitope Antibody Targeting Ovarian and Uterine Cancer at the AACR Annual Meeting 2016 29
Clinical Trial Profile Snapshots 30
Appendix 939
Abbreviations 939
Definitions 939
Research Methodology 940
Secondary Research 940
About GlobalData 941
Contact Us 941
Disclaimer 941
Source 942
List of Figures
List of Tables
Uterine Cancer Therapeutics, Global, Clinical Trials by Region, 2016* 6
Uterine Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Uterine Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Uterine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Uterine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Uterine Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Uterine Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
Uterine Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Uterine Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 14
Uterine Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Uterine Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Uterine Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 17
Uterine Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Uterine Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Uterine Cancer Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Uterine Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Uterine Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Uterine Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Uterine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Uterine Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25

4. Uterine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Uterine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Uterine Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
List of Figures
Uterine Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Uterine Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Uterine Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Uterine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Uterine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Uterine Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Uterine Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
Uterine Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Uterine Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 14
Uterine Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Uterine Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Uterine Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 17
Uterine Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Uterine Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Uterine Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Uterine Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Uterine Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Uterine Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Uterine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Uterine Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Uterine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Uterine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Uterine Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 940
Companies Profiled
GlaxoSmithKline Plc
Merck & Co., Inc.
AstraZeneca Plc
F. Hoffmann-La Roche Ltd.
Novartis AG
Sanofi
Bristol-Myers Squibb Company
Pfizer Inc.
Eli Lilly and Company
Pharma Mar, S.A.

5. Click here Request for Discount @: https://marketreportscenter.com/request-
discount/310629
About Us:
Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts,
professionals who are subject to market research information for their work, or to make strategic
business decisions. Market Reports Center’s team consistently works to update and extend our existing
repository of market research reports by partnering with new publishers and adding their studies to our
website.
Contact Us:
Sam Collins
(International Sales Manager)
Market Reports Center
Phone No: +1-646-883-3044 (US)
Mail: info@marketreportscenter.com
Visit Our Blog: http://marketreportscenter.blogspot.in/